News

Integration of Artificial Intelligence with Digital Pathology: Deployment Considerations & Cases Studies in Pharma

Events, HALO, HALO AI, News, Past Webinars, Webinars / ,

24 April 2019 | By helping scientists make data-driven decisions faster and more efficiently, artificial intelligence (AI) is revolutionizing drug discovery and development.  Pathology is no exception and the Pathology Sciences team at AstraZeneca in Cambridge UK is leading the charge.  Here, neural networks are being deployed to search digital slides for specific tissue classes, features and pathologies that are not easily quantified using traditional image analysis or are too time-consuming for pathologists to quantify by eye.

Integration of Artificial Intelligence with Digital Pathology: Deployment Considerations & Cases Studies in Pharma Read More »

Automated Analysis of Lymphocytic Infiltration, Tumor Budding, and Their Spatial Relationship Improves Prognostic Accuracy in Colorectal Cancer

News, Publications

Both immune profiling and tumor budding significantly correlate with colorectal cancer patient outcome but are traditionally reported independently. This study evaluated the association and interaction

Automated Analysis of Lymphocytic Infiltration, Tumor Budding, and Their Spatial Relationship Improves Prognostic Accuracy in Colorectal Cancer Read More »

Press Release: Fluidigm Announces Co-Marketing Agreement with Indica Labs to Offer Platform for Imaging Mass Cytometry Data Analysis to Aid Novel Digital Pathology Investigations

News, Press Releases

SOUTH SAN FRANCISCO, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ: FLDM) and Indica Labs, Inc., today announced a co-marketing relationship for scalable and

Press Release: Fluidigm Announces Co-Marketing Agreement with Indica Labs to Offer Platform for Imaging Mass Cytometry Data Analysis to Aid Novel Digital Pathology Investigations Read More »

Transforming tissue-based translational research with advanced multiplexing technologies, image analysis and cloud collaboration

Events, HALO, HALO Link, HALO Modules, Highplex FL, News, Past Webinars, Webinars / , , ,

25 October 2018 | With its high spatial heterogeneity and biological complexity, the tumor immune microenvironment presents a characterization challenge for translational researchers. Conventional immunohistochemistry (IHC) methods only provide insight into a limited number of markers of interest. In this 60-minute webinar, Dr. Sean Downing from Ultivue will explain how they are overcoming these limitations and extracting meaningful, highly multiplexed biomarker data from whole slide images using Ultivue’s proprietary multiplexing technology, UltiMapper™ I/O, in combination with the HALO® image analysis platform. He will describe how Ultivue’s technology works with existing stains and scanners, and finally, how Ultivue utilizes HALO LINK™ as its digital image management tool to facilitate remote access to biomarker data and secure file sharing with its customers across the world.

Transforming tissue-based translational research with advanced multiplexing technologies, image analysis and cloud collaboration Read More »

Free Demo
Free Demo
Scroll to Top